Download This Paper
Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.
Vitamin D Sufficiency Reduced Risk for Morbidity and Mortality in COVID-19 Patients
13 Pages Posted: 14 Jul 2020
More...Abstract
The aim of the study was to investigate the association between serum 25-hydroxyvitamin D levels and its effect on adverse clinical outcomes, parameters of immune function and mortality due to a SARS-CoV-2 infection.
Method: Hospital medical records were analyzed from inpatient database of Sina Hospital COVID-19 Registry (SHCo-19R). The data include demographics, laboratory measurements and computerized tomography results. Vitamin D sufficiency was defined a serum 25-hydroxyvitamin D [25(OH)D] level of at least 30ng/mL.
Results: The hospital data of 235 patients infected with COVID-19 were analyzed. The mean age was 58·7 years ± 15·2 SD. Based on CDC criteria, among our study patients, 74% had severe COVID-19 infection and 32·8% were vitamin D sufficient [25(OH)D≥30 ng/mL]. After adjusting for confounding factors, there was a significant association between vitamin D sufficiency and reduction in clinical severity, inpatient mortality, serum levels of C-reactive protein (CRP)and an increase in lymphocyte percentage Only 9·7% of patients older than 40 years who were vitamin D sufficient succumbed to the infection compared to 20% who had a circulating level of 25(OH)D< 30 ng/mL.
Discussion: The significant reduction in serum CRP, an inflammatory marker, along with increased lymphocytes percentage suggest that vitamin D sufficiency also may help modulate the immune response possibly by reducing risk for cytokine storm in response to this viral infection. Therefore, it is recommended that improving vitamin D status in the general population and in particular hospitalized patients has a potential benefit in reducing the severity of morbidities and mortality associated with acquiring COVID-19.
Funding Statement: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors for trial design, data collection, or analysis.
Declaration of Interests: MFH former consultant for Quest Diagnostics, speakers Bureau for Abbott Inc., consultant Ontometrics Inc., all other authors declare that they have no conflict of interest.
Ethics Approval Statement: The current study was approved by the ethics review board at Tehran University of Medical Sciences (IR.TUMS.VCR.REC.1399.338).
Keywords: SARS-CoV-2; COVID-19; Vitamin D; 25-hydroxyvitamin D; immunomodulation; hypoxia; unconsciousness; lymphocyte; C-reactive protein; mortality; morbidity
Suggested Citation: Suggested Citation